Related Experiment Video
Updated: Jun 26, 2026
06:02
Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Microtubule dynamics as a target in oncology
April L Risinger1, Francis J Giles, Susan L Mooberry
1Department of Pharmacology, The University of Texas Health Science Center, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.
Cancer Treatment Reviews
|January 2, 2009
Summary
Microtubule-targeting agents, including taxanes and vinca alkaloids, are crucial cancer therapies. This review evaluates their development, efficacy, and toxicity for future therapeutic potential.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Microtubule dynamics are critical targets in cancer therapy.
- Taxanes and vinca alkaloids have long been used against leukemias and solid tumors.
- Novel microtubule-targeting agents are continually being developed and evaluated.
Purpose of the Study:
- To review the molecular mechanisms of microtubule-targeting agents.
- To analyze preclinical and clinical results of various agents.
- To assess the future development potential of these drugs based on efficacy and safety.
Main Methods:
- Literature review of molecular mechanisms.
- Analysis of preclinical data in animal models.
- Evaluation of clinical trial outcomes.
- Assessment of drug availability, efficacy, and toxicity profiles.
Main Results:
- Established agents like taxanes and vinca alkaloids remain important.
- Newer agents show promise, with some approved (e.g., ixabepilone).
- Several agents with preclinical success failed in clinical trials due to inefficacy or toxicity.
Conclusions:
- Continued research into microtubule-targeting agents is vital for cancer treatment.
- Careful evaluation of efficacy, toxicity, and availability is necessary for drug development.
- Optimizing microtubule-targeting agents may lead to improved cancer therapies.
Related Concept Videos
01:45Destabilization of Microtubules
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:23Microtubule Formation
Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation of...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...